Efficacy of intravenous versus topical administration of tranexanmic acid in primary total knee arthroplasty

doi:10.3969/j.issn.2095-4344.0030

Abstract

Abstract:

BACKGROUND: Blood loss is a significant concern for patients undergoing total knee arthroplasty (TKA). Increasing evidence has shown that tranexamic acid is effective in decreasing perioperative blood loss in TKA.

OBJECTIVE: To compare the efficacy of two methods of tranexanmic acid administration on the perioperative blood loss in primary TKA.

METHODS: Totally 105 patients with unilateral knee osteoarthritis undergoing TKA were randomly allocated to three groups: 1 g of tranexanmic acid was administered intravenously before and after wound closure (group A); 2 g of tranexanmic acid in 20 mL of normal saline was injected into the articualr cavity through the drainage after wound closure and the tube was clamped for 4 hours (group B); no tranexanmic acid administration (group C). The intraoperative blood loss, hemoglobin level at postoperative 24 and 48 hours, postoperative drainage volume and incidence of deep venous thrombosis were recorded.

RESULTS AND CONCLUSION: (1) The intraoperative blood loss and postoperative drainage volume in the groups A and B were significantly less than those in the group C (P < 0.05); the postoperative hemoglobin level in the group A was higher than that in the group B; the postoperative drainage volume in the group B was less than that in the group A; the total blood loss in the group A was significantly less than that in the group B (P < 0.05). (2) None patient appeared with lower limb deep venous thrombosis. (3) These findings indicate that intravenous and topical administration of tranexamic acid can significantly reduce the perioperative blood loss in primary TKA, and cannot increase the risk of thrombosis.

中国组织工程研究杂志出版内容重点：人工关节；骨植入物；脊柱；骨折；内固定；数字化骨科；组织工程

Key words: Arthroplasty, Replacement, Knee, Tranexanic Acid, Prosthesis Implantation, Tissue Engineering

CLC Number:

R318

Hu Wen-hao. Efficacy of intravenous versus topical administration of tranexanmic acid in primary total knee arthroplasty[J]. Chinese Journal of Tissue Engineering Research, 2018, 22(3): 356-361.

Figures/Tables 3

References

[1] Panteli M, Papakostidis C, Dahabreh Z, et al. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee. 2013;20(5):300.

[2] Spahn DR, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology. 2000;93(1): 242-255.

[3] Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999,57(6): 1005-1032.

[4] Soliman R, Yousef H, Alghadam F, et al. Prospective, Randomized, comparative study between aprotinin and tranexamic acid in cardiac surgery. J Anesthes Clin Res. 2013;2(1):201-205.

[5] Calamari D, Zuccato E, Castiglioni S, et al. Strategic survey of therapeutic drugs in the Rivers Po And Lambro in northern Italy. Env Scie Technol. 2015;37(7):1241-1248.

[6] Sanz-Reig J, Parra RB, Ferrández MJ, et al. Single intravenous tranexamic acid dose to reduce blood loss in primary total knee replacement. Rev Esp Cir Ortop Traumatol. 2016;60(2):106-112.

[7] Chen JY, Chin PL, Moo IH, et al. Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: A double-blinded randomised controlled noninferiority trial. Knee. 2016;23(1):152-156.

[8] Gillette BP, Desimone LJ, Trousdale RT, et al. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res. 2013;471(1):150-154.

[9] Hynes M, Calder P, Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee. 2003; 10(4):375-377.

[10] Kagoma YK, Crowther MA, Douketis J, et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res. 2009;123(5):687.

[11] Madsen RV, Nielsen CS, Kallemose T, et al. Low risk of thromboembolic events after routine administration of tranexamic acid in hip and knee arthroplasty. J Arthroplasty. 2017;32(4):1298-1303.

[12] Zhu M, Chen JY, Yew AK, et al. Intra-articular tranexamic acid wash during bilateral total knee arthroplasty. J Orthop Surg (Hong Kong). 2015;23(3):290-293.

[13] May JH, Rieser GR, Williams CG, et al. The assessment of blood loss during total knee arthroplasty when comparing intravenous vs intracapsular administration of tranexamic acid. J Arthroplasty. 2016;31(11):2452-2457.

[14] Sun Q, Yu X, Nie X, et al. The efficacy comparison of tranexamic acid for reducing blood loss in total knee arthroplasty at different dosage time. J Arthroplasty. 2017; 32(1):33-36.

[15] Shin YS, Yoon JR, Lee HN, et al. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2016;23(105):1-11.

[16] Sadigursky D, Andion D, Boureau P, et al. Effect of tranexamic acid on bleeding control in total knee arthroplasty. Acta Ortop Bras. 2016;24(3):131-136.

[17] Digas G, Koutsogiannis I, Meletiadis G, et al. Intra-articular injection of tranexamic acid reduce blood loss in cemented total knee arthroplasty. Eur J Orthop Surg Traumatol. 2015; 25(7):1181-1188.

[18] Vijay BS, Vikram B, Subhro M, et al. Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi J Anaesth. 2013;7(1):29-32.

[19] Rasouli MR, Parvizi J. Tranexamic Acid in total joint arthroplasty: efficacy and safety. Arch Bone Joint Surg. 2015; 3(1):1.

[20] Aglietti P, Baldini A, Vena LM, et al. Effect of tourniquet use on activation of coagulation in total knee replacement. Clin Orthop Relat Res. 2000;371(371):169.

[21] Darina DCL, Pablo MH, Flores YN, et al. Influence of mealtime habits on the risk of weight gain and obesity in Mexican adults. Public Health Nutr. 2016;20(2):220-232.

[22] Wong J, Abrishami A, El BH, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am. 2010;92(15):2503.

[23] Hirotaka M, Kotaro I. Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J Orthop Surg Res. 2012; 7(1):1-6.

[24] Irwin A, Khan SK, Jameson SS, et al. Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Joint J. 2013;95-B(11):1556.

[25] Pongcharoen B, Ruetiwarangkoon C. Does tranexamic acid reduce blood loss and transfusion rates in unicompartmental knee arthroplasty. J Orthop Sci. 2016;21(2):211-215.

[26] Valentine SL, Randolph AG. Weaning children from mechanical ventilator support// Pediatric and neonatal mechanical ventilation. Springer Berlin Heidelberg, 2015.

[27] Alipour M, Tabari M, Keramati M, et al. Effectiveness of oral Tranexamic acid administration on blood loss after knee artroplasty: a randomized clinical trial. Transfus Apher Sci. 2013;49(3):574-577.

[28] Zohar E, Ellis M, Ifrach N, et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesthesia Analgesia. 2004;99(6):1679-1683.

[29] Rosenstein AD, Michelov YA, Thompson S, et al. Benefits of limited use of a tourniquet combined with intravenous tranexamic acid during total knee arthroplasty. Ochsner J. 2016;16(4):443-449.

[30] Lin PC, Hsu CH, Chen WS, et al. Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clini Orthop Relat Res. 2011;469(7):1995-2002.

[31] Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesthesia. 2003;90(5):596.

[32] Mahdi M, Ali TM, Mehdi S, et al. Low dose perioperative intravenous tranexamic acid in patients undergoing total knee arthroplasty: a double-blind randomized placebo controlled clinical trial. J Blood Transfus. 2015;2015(1):1-5.

[33] Ishida K, Tsumura N, Kitagawa A, et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop. 2011; 35(11):1639-1645.

[34] Loš?ák J, Gallo J, Špi?ka J, et al. Intra-articular application of tranexamic acid significantly reduces blood loss and transfusion requirement in primary total knee arthroplasty. Acta Chir Orthop Traumatol Cech. 2016;83(4):254-262.

[35] Pinsornsak P, Rojanavijitkul S, Chumchuen S. Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial. BMC Musculoskelet Disord.2016; 17(32):313.

[36] Danninger T, Rasul R, Poeran J, et al. Blood transfusions in total hip and knee arthroplasty: an analysis of outcomes. Thescient World J. 2014; 2014(2):623460.

[37] Wong J, Abrishami A, El BH, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am. 2010;92(15):2503-2513.

[38] DiBlasi JF, Smith RP, Garavaglia J, et al. Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. Am J Orthop (Belle Mead NJ). 2016;45(7):E439-439E443.

[39] Shang J, Wang H, Zheng B, et al. Combined intravenous and topical tranexamic acid versus intravenous use alone in primary total knee and hip arthroplasty: A meta-analysis of randomized controlled trials. Int J Surg. 2016;36(Pt A): 324-329.

[40] Delanois RE, Gwam C, Mistry JB, et al. Intraarticular administration of tranexamic acid is safe and effective in total knee arthroplasty patients at high-risk for thromboembolism. Surg Technol Int. 2016;30(205):279-283.

[41] Fu Y, Shi Z, Han B, et al. Comparing efficacy and safety of 2 methods of tranexamic acid administration in reducing blood loss following total knee arthroplasty: A meta-analysis. Medicine (Baltimore). 2016;95(50):e5583.

[42] He P, Zhang Z, Li Y, et al. Efficacy and safety of tranexamic acid in bilateral total knee replacement: a meta-analysis and systematic review. Med Sci Monit. 2015;21(30):3634-3642.